Iloprost in Preventing Lung Cancer in Former Smokers
Status:
Active, not recruiting
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This phase I trial studies the side effects and best dose of iloprost compared with a placebo
in preventing lung cancer in former smokers. Chemoprevention is the use of drugs to keep
cancer from forming or coming back. Inhaled iloprost may help prevent lung cancer from
forming in patients who used to smoke and who have been found to have abnormal cells in their
mucus.